Effective medicines exist to treat or alleviate many diseases which predominate in the developing world and cause high mortality and morbidity rates. Price should not be an obstacle preventing access to these medicines. Increasingly, drug donations have been established by drug companies, but these are often limited in time, place or use. Measures exist which are more sustainable and will have ...

Classical single-factor comparable company valuation (CCV) like e.g. valuation using the price-earnings ratio is associated with several shortcomings. The two most important are the non-applicability of negative values in the basis of reference and the high requirements to the qualitative characteristics of comparable companies. This paper develops a multi-factor CCV model based on substance an...

PURPOSE Medical students are at-risk to the influence of pharmaceutical company (Pharma) marketing. As interactions with the industry come under increasing scrutiny and regulation, previous studies on student-Pharma relations no longer may be accurate. This study assessed students' attitudes toward and interactions with Pharmas at the University of Wisconsin School of Medicine and Public Health...

The parts manufacturing companies should select a proper strategy according to their current and future environmental conditions and capabilities to survive and thrive in competitive market. To help the companies to select the best strategy the current paper proposes a model. The model is developed using a number of strategic tools, including TOPSIS, SWOT analysis and Six Paths Framework to For...

the performance evaluation and efficiency measurement of software companies and compare them together as a set of knowledge-based activities due to the unknown of internal processes and stages common to these companies and ignoring these processes in performance evaluation by data envelopment analysis models and how to consider these processes and procedures for calculating efficiency of each s...